These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21167891)

  • 1. Chronic treatment with a stable obestatin analog significantly alters plasma triglyceride levels but fails to influence food intake; fluid intake; body weight; or body composition in rats.
    Agnew A; Calderwood D; Chevallier OP; Greer B; Grieve DJ; Green BD
    Peptides; 2011 Apr; 32(4):755-62. PubMed ID: 21167891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral administration of TAT-obestatin can influence the expression of liporegulatory genes but fails to affect food intake in mice.
    Ren G; He Z; Cong P; Chen H; Guo Y; Yu J; Liu Z; Ji Q; Song Z; Chen Y
    Peptides; 2013 Apr; 42():8-14. PubMed ID: 23313740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment analogs as better mimics of obestatin.
    Nagaraj S; Peddha MS; Manjappara UV
    Regul Pept; 2009 Nov; 158(1-3):143-8. PubMed ID: 19712707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents.
    Gourcerol G; Coskun T; Craft LS; Mayer JP; Heiman ML; Wang L; Million M; St-Pierre DH; Taché Y
    Obesity (Silver Spring); 2007 Nov; 15(11):2643-52. PubMed ID: 18070755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of obestatin in rat and human stomach and plasma, and its lack of acute effect on feeding behavior in rodents.
    Mondal MS; Toshinai K; Ueno H; Koshinaka K; Nakazato M
    J Endocrinol; 2008 Aug; 198(2):339-46. PubMed ID: 18480381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation.
    Khaleel EF; Abdel-Aleem GA
    Arch Physiol Biochem; 2019 Feb; 125(1):64-78. PubMed ID: 29429367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obestatin reduces food intake and suppresses body weight gain in rodents.
    Lagaud GJ; Young A; Acena A; Morton MF; Barrett TD; Shankley NP
    Biochem Biophys Res Commun; 2007 May; 357(1):264-9. PubMed ID: 17418097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of chronic obestatin infusion in rats.
    Unniappan S; Speck M; Kieffer TJ
    Peptides; 2008 Aug; 29(8):1354-61. PubMed ID: 18508160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of obestatin on feeding and body weight after standard or cafeteria diet in the rat.
    Brunetti L; Leone S; Orlando G; Recinella L; Ferrante C; Chiavaroli A; Di Nisio C; Di Michele P; Vacca M
    Peptides; 2009 Jul; 30(7):1323-7. PubMed ID: 19397941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of OB protein decreases food intake by selectively reducing meal size in female rats.
    Eckel LA; Langhans W; Kahler A; Campfield LA; Smith FJ; Geary N
    Am J Physiol; 1998 Jul; 275(1):R186-93. PubMed ID: 9688978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent modulation of central ghrelin effects on food intake and lipid metabolism in rats.
    Nesic DM; Stevanovic DM; Stankovic SD; Milosevic VL; Trajkovic V; Starcevic VP; Severs WB
    Eur J Pharmacol; 2013 Jun; 710(1-3):85-91. PubMed ID: 23603525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus.
    Xu J; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
    Int J Biol Macromol; 2011 Nov; 49(4):657-62. PubMed ID: 21756932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone and dexamethasone both stimulate energy acquisition whereas only the glucocorticoid alters energy storage.
    Santana P; Akana SF; Hanson ES; Strack AM; Sebastian RJ; Dallman MF
    Endocrinology; 1995 May; 136(5):2214-22. PubMed ID: 7720670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrally applied ghrelin affects feeding dynamics in male rats.
    Nesić DM; Stevanović DM; Ille T; Petricević S; Masirević-Drasković G; Starcević VP
    J Physiol Pharmacol; 2008 Sep; 59(3):489-500. PubMed ID: 18953092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 18-methoxycoronaridine on ghrelin-induced increases in sucrose intake and accumbal dopamine overflow in female rats.
    McCallum SE; Taraschenko OD; Hathaway ER; Vincent MY; Glick SD
    Psychopharmacology (Berl); 2011 May; 215(2):247-56. PubMed ID: 21210086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longer-term fourth ventricular 5-thioglucose infusion increases body fat in the rat.
    He B; White BD; Edwards GL; Martin RJ
    Proc Soc Exp Biol Med; 1998 Feb; 217(2):168-72. PubMed ID: 9452140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different responses of circulating ghrelin, obestatin levels to fasting, re-feeding and different food compositions, and their local expressions in rats.
    Guo ZF; Ren AJ; Zheng X; Qin YW; Cheng F; Zhang J; Wu H; Yuan WJ; Zou L
    Peptides; 2008 Jul; 29(7):1247-54. PubMed ID: 18400333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ghrelin/obestatin balance in the physiological and pathological control of growth hormone secretion, body composition and food intake.
    Hassouna R; Zizzari P; Tolle V
    J Neuroendocrinol; 2010 Jul; 22(7):793-804. PubMed ID: 20456603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obestatin as a regulator of adipocyte metabolism and adipogenesis.
    Gurriarán-Rodríguez U; Al-Massadi O; Roca-Rivada A; Crujeiras AB; Gallego R; Pardo M; Seoane LM; Pazos Y; Casanueva FF; Camiña JP
    J Cell Mol Med; 2011 Sep; 15(9):1927-40. PubMed ID: 21029370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver function.
    Kołodziejski PA; Pruszyńska-Oszmałek E; Strowski MZ; Nowak KW
    Endocrine; 2017 Jun; 56(3):538-550. PubMed ID: 28477305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.